日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Enhancing the Efficacy of HIPEC Through Bromelain: A Preclinical Investigation in Appendiceal Cancer

通过菠萝蛋白酶增强 HIPEC 的疗效：阑尾癌的临床前研究

期刊:Annals of Surgical Oncology
影响因子:3.4
doi:10.1245/s10434-024-15355-0
Nadeem Wajih, Richard A Erali, Steven D Forsythe, Cecilia R Schaaf, Perry Shen, Edward A Levine, Shay Soker, David L Morris, Konstantinos I Votanopoulos
免疫
阑尾炎
发表日期：2024
文献求助 收藏

Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications

用于个性化转化研究的患者特异性肉瘤类器官：手术室与罕见癌症研究的统一及其临床意义

期刊:Annals of Surgical Oncology
影响因子:3.4
doi:10.1245/s10434-022-12086-y
Steven D Forsythe #, Hemamylammal Sivakumar #, Richard A Erali, Nadeem Wajih, Wencheng Li, Perry Shen, Edward A Levine, Katherine E Miller, Aleksander Skardal, Konstantinos I Votanopoulos8
肿瘤
发表日期：2022
文献求助 收藏

Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study

类器官平台在阑尾癌个性化免疫治疗疗效临床前研究中的可行性研究

期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-21-0982
Steven D Forsythe, Richard A Erali, Shyama Sasikumar, Preston Laney, Ethan Shelkey, Ralph D'Agostino Jr, Lance D Miller, Perry Shen, Edward A Levine, Shay Soker, Konstantinos I Votanopoulos
免疫
阑尾炎
发表日期：2021
文献求助 收藏

Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform

患者源性肿瘤类器官平台中最优HIPEC灌注方案的个性化识别

期刊:Annals of Surgical Oncology
影响因子:3.4
doi:10.1245/s10434-020-08790-2
Steven D Forsythe, Shyama Sasikumar, Omeed Moaven, Hemamylammal Sivakumar, Perry Shen, Edward A Levine, Shay Soker, Aleksander Skardal, Konstantinos I Votanopoulos
肿瘤
发表日期：2020
文献求助 收藏